127 related articles for article (PubMed ID: 30452488)
1. SignalDetDDI: An SAS macro for detecting adverse drug-drug interactions in spontaneous reporting systems.
Gosho M; Ohigashi T; Maruo K
PLoS One; 2018; 13(11):e0207487. PubMed ID: 30452488
[TBL] [Abstract][Full Text] [Related]
2. Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy.
Leone R; Magro L; Moretti U; Cutroneo P; Moschini M; Motola D; Tuccori M; Conforti A
Drug Saf; 2010 Aug; 33(8):667-75. PubMed ID: 20635825
[TBL] [Abstract][Full Text] [Related]
3. Data-driven prediction of adverse drug reactions induced by drug-drug interactions.
Liu R; AbdulHameed MDM; Kumar K; Yu X; Wallqvist A; Reifman J
BMC Pharmacol Toxicol; 2017 Jun; 18(1):44. PubMed ID: 28595649
[TBL] [Abstract][Full Text] [Related]
4. Identification of adverse drug reactions in geriatric inpatients using a computerised drug database.
Egger T; Dormann H; Ahne G; Runge U; Neubert A; Criegee-Rieck M; Gassmann KG; Brune K
Drugs Aging; 2003; 20(10):769-76. PubMed ID: 12875612
[TBL] [Abstract][Full Text] [Related]
5. A 6-year retrospective study of adverse drug reactions due to drug-drug interactions between nervous system drugs.
Shi QP; He XD; Yu ML; Zhu JX; Liu Y; Ding F; Sang R; Jiang XD; Zhang SQ
Int J Clin Pharmacol Ther; 2014 May; 52(5):392-401. PubMed ID: 24691061
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Three Different Data Sources of Adverse Drug Reactions Using Adverse Drug Reaction Data of Fluorouracil for Gastric Cancer as an Example.
Niu R; Chen Y; Xiang Y; Liu Y; Guo J; Feng B
Biol Pharm Bull; 2020; 43(10):1476-1480. PubMed ID: 32999157
[TBL] [Abstract][Full Text] [Related]
7. Adverse drug reaction reporting: how can drug consumption information add to analyses using spontaneous reports?
Svendsen K; Halvorsen KH; Vorren S; Samdal H; Garcia B
Eur J Clin Pharmacol; 2018 Apr; 74(4):497-504. PubMed ID: 29255992
[TBL] [Abstract][Full Text] [Related]
8. Adverse drug reactions caused by drug-drug interactions in cardiovascular disease patients: introduction of a simple prediction tool using electronic screening database items.
Kovačević M; Vezmar Kovačević S; Radovanović S; Stevanović P; Miljković B
Curr Med Res Opin; 2019 Nov; 35(11):1873-1883. PubMed ID: 31328967
[No Abstract] [Full Text] [Related]
9. The importance of monitoring adverse drug reactions in elderly patients: the results of a long-term pharmacovigilance programme.
Carnovale C; Gentili M; Fortino I; Merlino L; Clementi E; Radice S; ViGer Group
Expert Opin Drug Saf; 2016; 15(2):131-9. PubMed ID: 26882049
[TBL] [Abstract][Full Text] [Related]
10. Supervised signal detection for adverse drug reactions in medication dispensing data.
Hoang T; Liu J; Roughead E; Pratt N; Li J
Comput Methods Programs Biomed; 2018 Jul; 161():25-38. PubMed ID: 29852965
[TBL] [Abstract][Full Text] [Related]
11. Monitoring drug safety in Astrakhan, Russia.
Kirilochev OO; Dorfman IP; Umerova AR
Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
[TBL] [Abstract][Full Text] [Related]
12. A Text Mining Protocol for Predicting Drug-Drug Interaction and Adverse Drug Reactions from PubMed Articles.
Shukkoor MSA; Raja K; Baharuldin MTH
Methods Mol Biol; 2022; 2496():237-258. PubMed ID: 35713868
[TBL] [Abstract][Full Text] [Related]
13. Adverse Drug Reactions Related to Drug Administration in Hospitalized Patients.
Gallelli L; Siniscalchi A; Palleria C; Mumoli L; Staltari O; Squillace A; Maida F; Russo E; Gratteri S; De Sarro G;
Curr Drug Saf; 2017; 12(3):171-177. PubMed ID: 28625147
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of drug safety information using large-scale adverse drug reactions database].
Morikawa K
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2011; (129):1-26. PubMed ID: 22259840
[TBL] [Abstract][Full Text] [Related]
15. Study on the Increased Probability of Detecting Adverse Drug Reactions Based on Bayes' Theorem: Evaluation of the Usefulness of Information on the Onset Timing of Adverse Drug Reactions.
Oshima S; Enjuji T; Negishi A; Akimoto H; Ohara K; Okita M; Numajiri S; Inoue N; Ohshima S; Terao A; Kobayashi D
Biol Pharm Bull; 2017 Sep; 40(9):1389-1398. PubMed ID: 28579595
[TBL] [Abstract][Full Text] [Related]
16. A computerized system for detecting signals due to drug-drug interactions in spontaneous reporting systems.
Qian Y; Ye X; Du W; Ren J; Sun Y; Wang H; Luo B; Gao Q; Wu M; He J
Br J Clin Pharmacol; 2010 Jan; 69(1):67-73. PubMed ID: 20078614
[TBL] [Abstract][Full Text] [Related]
17. Adverse drug reactions in Colombian patients, 2007-2013: Analysis of population databases.
Machado-Alba JE; Londoño-Builes MJ; Echeverri-Cataño LF; Ochoa-Orozco SA
Biomedica; 2016 Mar; 36(1):59-66. PubMed ID: 27622439
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
19. Linking biochemical pathways and networks to adverse drug reactions.
Zheng H; Wang H; Xu H; Wu Y; Zhao Z; Azuaje F
IEEE Trans Nanobioscience; 2014 Jun; 13(2):131-7. PubMed ID: 24893363
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of drug-drug interactions in hospitalized dermatology patients.
Ganeva M; Gancheva T; Troeva J; Kiriyak N; Hristakieva E
Adv Clin Exp Med; 2013; 22(4):555-63. PubMed ID: 23986216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
